News
| EVIDENT, 89 North and CrestOptics Collaborate to Advance Live-Cell Imaging Evident, 89 North, and CrestOptics announced a collaborative agreement to promote confocal spinning-disk technology to advance live-cell imaging in the Americas, expanding the range of imaging options available to researchers. Read the press release for all the details. |
| The DP75 Digital Microscope Camera Empowers Microscopic Discoveries and Inspections Our new DP75 digital microscope camera is breaking new ground in microscopic imaging! Users can now capture brightfield or wide-wavelength fluorescence images using a single color camera. And that’s just the beginning. Check out the press release for details about this high-end camera’s new features. |
| Evident Aligns Business Unit Structure to Best Meet Customer Needs Evident was established as a standalone company in April 2023, comprising the former Scientific Solutions business of Olympus, marking a significant milestone in the development of our new company. |
| Elevate Your Imaging with New FLUOVIEW™ Laser Scanning Microscope Systems Introducing the FLUOVIEW™ FV4000 confocal laser scanning microscope and FV4000MPE multiphoton laser scanning microscope—groundbreaking advancements in imaging technology that empower researchers to make new scientific discoveries. Learn about all the new features and functions in the press release. |
| EVIDENT Announces Alliance to Automate Digital Pathology Workflows We have announced an alliance with Corista, Sakura Finetek USA, and Visiopharm to deliver an automated, end-to-end workflow solution for pathology. Get all the details in the press release. |
| 胃がんAI病理診断支援ソフトウェア、連続症例における評価でAUC0.96を達成 独立行政法人国立病院機構呉医療センター・中国がんセンター（院長：下瀨 省二）を含む国内医療機関7施設との共同研究で開発した胃がんAI病理診断支援ソフトウェアが、学習データに使用していない施設での連続症例における評価でAUC0.96を達成しました。 |
| EVIDENT Corporation Appoints New CEO and COO Evident Corporation (“Evident”) announced the appointment of William Wesley “Wes” Pringle as Chief Executive Officer (CEO) and Hiroyuki Yoshimoto as President and Chief Operating Officer (COO). Effective immediately, Wes takes over for Evident’s interim CEO Eric Anderson. |
| EVIDENT Announces 2022 Global Image of the Year Award Winners The results are in! Discover the winners of our 2022 Global Image of the Year Scientific Light Microscopy Award, an annual competition that recognizes the best in scientific imaging worldwide. Learn more in the press release. |
| EVIDENT Discovery Center Inaugurated at the University of Montreal |
| The SLIDEVIEW™ DX Combines Microscope-Quality Images with Fast Slide Scanning for Efficient Digital Pathology |
| ホールスライドイメージングシステム「SLIDEVIEW VS-M1J」を発売 株式会社エビデント（本社：東京都新宿区、社長：エリック アンダーソン）は、病理検査向けにスライドガラス標本を画像データ化するホールスライドイメージングシステム「SLIDEVIEW VS-M1J（スライドビュー ヴイエス-エムワンジェイ）」を2023年6月1日より国内で発売します。 |
| Evident Announces Interim CEO Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective immediately. |
| SLIDEVIEW™ VS200 Adds Optical Sectioning Device for High-Contrast, Blur-Free Imaging |
| Evident Acquired by Bain Capital: Partnership to Accelerate Future Growth and Innovation |
| Notice Concerning Postponement of Closing of Transfer of Shares of Evident Corporation |
| Postponement of the Transfer of all Shares of EVIDENT Corporation from Olympus to Bain Capital |
| 2023 EVIDENT Organoid Conference to Share the Latest Organoid Innovations |
No posts found for this year. Please try another year above.
Not Available in Your Country
Sorry, this page is not
available in your country.